Transforming Alzheimer’s Disease
Early, accurate, predictive, fast, non-invasive
and cost-effective diagnosis of Alzheimer’s Disease
20 Years or more before symptoms appear
33 Million Alzheimer dementia patients worldwide
152 Million dementia patients estimated by 2050
US $1 Trillion estimated global annual cost of dementia
%
More than 50% of dementia cases are undiagnosed in high-income countries
Take action on Alzheimer’s Disease
AlzoSure® Predict is a simple blood test that can predict the risk of Alzheimer’s Disease up to 6 years in advance by identifying the U-p52 AZ biomarker, a conformational variant associated with the early stages of Alzheimer’s Disease.
For patients
Value proposition information
For clinicians
Value proposition information
For researchers
Value proposition information
Title of additional section
Additional paragraph section – AlzoSure® Predict is a simple blood test that can predict the risk of Alzheimer’s Disease up to 6 years in advance by identifying the U-p52 AZ biomarker, a conformational variant associated with the early stages of Alzheimer’s Disease.
Diagnosis of Alzheimer’s Disease can take up to two years – but many patients are misdiagnosed leaving them unable to plan for the future or mean they miss out on potential life-changing treatments.
Are you concerned about Alzheimer’s Disease for yourself or a loved one?
Click here to take our questionnaire.